Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. RPRX
RPRX logo

RPRX News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

RPRX News

Royalty Pharma Reports Strong Q1 Earnings Growth

May 07 2026NASDAQ.COM

Royalty Pharma Q1 2026 Earnings Call Highlights

May 06 2026seekingalpha

Royalty Pharma Reports Q1 Revenue Growth of 11.1% but Misses Expectations

May 06 2026seekingalpha

Royalty Pharma to Announce Q1 Earnings on May 6

May 05 2026seekingalpha

Royalty Pharma Launches Translational Medicine Prize

Apr 21 2026Newsfilter

Royalty Pharma Announces Q2 2026 Dividend Payment

Apr 17 2026Newsfilter

Royalty Pharma Partners with Johnson & Johnson in $500M R&D Deal

Mar 30 2026seekingalpha

Royalty Pharma and Johnson & Johnson Sign $500 Million Co-Funding Agreement

Mar 30 2026NASDAQ.COM

RPRX Events

No data

No data

RPRX Monitor News

Royalty Pharma Reports Strong Q1 Earnings Growth

May 13 2026

Royalty Pharma announces Q2 2026 dividend payment

Apr 17 2026

Royalty Pharma partners with Johnson & Johnson for $500M R&D deal

Mar 31 2026

RPRX Earnings Analysis

Royalty Pharma Earnings: Q3 2025 Highlights & Analysis- Intellectia AI™
6 months ago
Royalty Pharma Q2 2025: Strong Growth & Investor Confidence- Intellectia AI™
9 months ago
Royalty Pharma's Rising Fortunes - Intellectia AI™
1 years ago

People Also Watch